These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. L-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis. Monaghan DT; Yao D; Cotman CW Brain Res; 1985 Aug; 340(2):378-83. PubMed ID: 2862960 [TBL] [Abstract][Full Text] [Related]
30. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus. Moncada C; Arvin B; Le Peillet E; Meldrum BS Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508 [TBL] [Abstract][Full Text] [Related]
31. Structure-function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that beta-L-ODAP is a selective non-NMDA agonist. Bridges RJ; Stevens DR; Kahle JS; Nunn PB; Kadri M; Cotman CW J Neurosci; 1989 Jun; 9(6):2073-9. PubMed ID: 2542485 [TBL] [Abstract][Full Text] [Related]
32. AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Kremer B; Tallaksen-Greene SJ; Albin RL Neurology; 1993 Aug; 43(8):1593-5. PubMed ID: 7688883 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. Zeman S; Lodge D Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781 [TBL] [Abstract][Full Text] [Related]
35. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029 [TBL] [Abstract][Full Text] [Related]
36. Are chimeric kainate/N-methyl-D-aspartate receptors expressed in Xenopus oocytes from mammalian and amphibian RNA? Brackley PT; Usherwood PN J Pharmacol Exp Ther; 1993 May; 265(2):910-9. PubMed ID: 7684447 [TBL] [Abstract][Full Text] [Related]
37. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. Raiteri M; Garrone B; Pittaluga A J Pharmacol Exp Ther; 1992 Jan; 260(1):238-42. PubMed ID: 1370541 [TBL] [Abstract][Full Text] [Related]
38. Synaptic localization of striatal NMDA, quisqualate and kainate receptors. Greenamyre JT; Young AB Neurosci Lett; 1989 Jun; 101(2):133-7. PubMed ID: 2549458 [TBL] [Abstract][Full Text] [Related]
39. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655 [TBL] [Abstract][Full Text] [Related]
40. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]